May 18, 2020

Jeffrey J. Popma, MD, to Join Medtronic

May 18, 2020—Medtronic announced that Jeffrey J. Popma, MD, will join the company as Vice President and Chief Medical Officer supporting the coronary, renal denervation, and structural heart businesses at Medtronic. Dr. Popma will officially assume his role with Medtronic on June 22, 2020, reporting to Nina Goodheart, President of the Coronary & Structural Heart division, which is part of the Cardiac and Vascular Group.

Dr. Popma is Professor of Medicine at Harvard Medical School and Director of Interventional Cardiology at Beth Israel Deaconess Medical Center in Boston, Massachusetts.

In providing medical leadership across the coronary, renal denervation, and structural heart businesses, Dr. Popma will serve as a strategic advisor for cardiovascular device innovation and assist in the development of an expanding clinical research portfolio, leveraging his expertise in interventional cardiology and transcatheter-based therapies, stated the company.

Medtronic noted that Dr. Popma is an internationally renowned interventional cardiologist, who is an expert in transcatheter aortic valve replacement and transcatheter mitral and tricuspid valve therapies. He is past president of the Society of Cardiac Angiography and Interventions and served as the chairman of the American College of Cardiology Cardiac Catheterization Committee.

Dr. Popma has directed numerous multicenter cardiovascular device clinical trials in a broad array of new technologies. He has published > 500 scientific articles in international peer-reviewed medical journals and has presented at hundreds of scientific sessions at national and international cardiology meetings. Additionally, he has published many textbook chapters on interventional cardiology and transcatheter valve replacement topics.

“I am honored to be joining Medtronic to help deliver on its enduring mission of patient-focused medical device innovation," commented Dr. Popma in the company's announcement. “I look forward to collaborating with the talented cardiovascular and structural heart teams at Medtronic and listening to the guidance of their clinical advisors to help develop product solutions and clinical evidence strategies for the betterment of patients.”

Dr. Popma continued, “I am also incredibly appreciative of the exceptional physicians and dedicated nurses who have supported me during my tenure at Beth Israel Deaconess Medical Center. I look forward to ongoing collaboration with these inspirational colleagues in the future.”


May 19, 2020

PROTECT III Evaluates Abiomed’s Impella Placement Before High-Risk PCI

May 18, 2020

Reduction in Patient Radiation Exposure Shown With Corindus' Robotic-Assisted Intervention